Clinical characteristics | TCGA (N = 432) | Univariate | Multivariate | ||
---|---|---|---|---|---|
HR (95% CI) | p value | HR (95% CI) | p value | ||
Age (years, mean ± sd) | 66.78 ± 12.88 | 1.018 (1.001–1.035) | 3.408E−02 | 1.047 (1.021–1.073) | 3.510E−04 |
Gender (male/female) | 230/202 | 1.077 (0.719–1.610) | 7.189E−01 | – | – |
Pathologic M (M0/M1/–) | 319/59/54 | 4.536 (2.851–7.218) | 2.649E−12 | 1.501 (0.373–6.036) | 5.671E− 01 |
Pathologic N (N0/N1/N2) | 254/101/77 | 2.088 (1.648–2.644) | 1.342E−10 | 1.614 (0.839–3.103) | 1.514E−01 |
Pathologic T(T1/T2/T3/T4) | 11/75/296/50 | 2.658 (1.775–3.979) | 1.116E−06 | 3.561 (1.781–7.121) | 3.280E−04 |
Pathologic stage (I/II/III/IV/–) | 73/167/123/59/10 | 2.181 (1.719–2.767) | 3.376E−11 | 1.123 (0.373–3.378) | 8.362E−01 |
Colon polyps history (yes/no/–) | 128/239/65 | 0.731 (0.426–1.255) | 2.537E− 01 | – | – |
Lymphatic invasion (yes/no/–) | 150/241/41 | 2.150 (1.392–3.320) | 4.125E− 04 | 0.922 (0.489–1.737) | 8.024E− 01 |
Recurrence (yes/no) | 78/292/62 | 2.567 (1.636–4.029) | 2.113E−05 | 1.881 (1.050–3.369) | 3.363E− 02 |
PS model status (high/low) | 216/216 | 3.287 (2.082–5.189) | 4.096E−08 | 2.737 (1.447–5.178) | 1.970E−03 |
Vital status (dead/alive) | 96/336 | – | – | – | – |
Overall survival time (months, mean ± sd) | 29.44 ± 25.43 | – | – | – | – |